274 related articles for article (PubMed ID: 17499752)
21. Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma during malignant melanoma progression.
Lee C; Ramirez JA; Guitart J; Diaz LK
J Cutan Pathol; 2008 Nov; 35(11):989-94. PubMed ID: 18537861
[TBL] [Abstract][Full Text] [Related]
22. Amentoflavone stimulates apoptosis in B16F-10 melanoma cells by regulating bcl-2, p53 as well as caspase-3 genes and regulates the nitric oxide as well as proinflammatory cytokine production in B16F-10 melanoma cells, tumor associated macrophages and peritoneal macrophages.
Guruvayoorappan C; Kuttan G
J Exp Ther Oncol; 2008; 7(3):207-18. PubMed ID: 19066129
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma.
Wang Y; Dai DL; Martinka M; Li G
Clin Cancer Res; 2007 Jul; 13(14):4111-6. PubMed ID: 17634537
[TBL] [Abstract][Full Text] [Related]
24. Analysis of APAF-1 expression in human cutaneous melanoma progression.
Baldi A; Santini D; Russo P; Catricalà C; Amantea A; Picardo M; Tatangelo F; Botti G; Dragonetti E; Murace R; Tonini G; Natali PG; Baldi F; Paggi MG
Exp Dermatol; 2004 Feb; 13(2):93-7. PubMed ID: 15009102
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of lipoxygenase pathway in macrophages co-cultivated with tumor cells.
Calorini L; Bianchini F; Mannini A; Mugnai G; Ruggieri S
Cancer Lett; 2005 Jun; 223(1):151-8. PubMed ID: 15890248
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.
Chwirot BW; Kuźbicki Ł
Melanoma Res; 2007 Jun; 17(3):139-45. PubMed ID: 17505259
[TBL] [Abstract][Full Text] [Related]
27. Mitogen-actived protein kinase activation is an early event in melanoma progression.
Cohen C; Zavala-Pompa A; Sequeira JH; Shoji M; Sexton DG; Cotsonis G; Cerimele F; Govindarajan B; Macaron N; Arbiser JL
Clin Cancer Res; 2002 Dec; 8(12):3728-33. PubMed ID: 12473582
[TBL] [Abstract][Full Text] [Related]
28. Expression of heat shock protein 105 and 70 in malignant melanoma and benign melanocytic nevi.
Park HS; Park CH; Choi BR; Lim MS; Heo SH; Kim CH; Kang SG; Whang KU; Cho MK
J Cutan Pathol; 2009 May; 36(5):511-6. PubMed ID: 19476517
[TBL] [Abstract][Full Text] [Related]
29. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
[TBL] [Abstract][Full Text] [Related]
30. [Influence of tumor-associated macrophages on progression and prognosis of nasopharyngeal carcinoma].
Peng J; Ding T; Zheng LM; Shao JY
Ai Zheng; 2006 Nov; 25(11):1340-5. PubMed ID: 17094898
[TBL] [Abstract][Full Text] [Related]
31. Blocking tumor cell eicosanoid synthesis by GP x 4 impedes tumor growth and malignancy.
Heirman I; Ginneberge D; Brigelius-Flohé R; Hendrickx N; Agostinis P; Brouckaert P; Rottiers P; Grooten J
Free Radic Biol Med; 2006 Jan; 40(2):285-94. PubMed ID: 16413410
[TBL] [Abstract][Full Text] [Related]
32. Cyclin-dependent kinase 2 expression in human melanomas and benign melanocytic skin lesions.
Kuźbicki L; Aładowicz E; Chwirot BW
Melanoma Res; 2006 Oct; 16(5):435-44. PubMed ID: 17013093
[TBL] [Abstract][Full Text] [Related]
33. The p44S10 locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanoma.
Ren S; Smith MJ; Louro ID; McKie-Bell P; Bani MR; Wagner M; Zochodne B; Redden DT; Grizzle WE; Wang Nd; Smith DI; Herbst RA; Bardenheuer W; Opalka B; Schütte J; Trent JM; Ben-David Y; Ruppert JM
Oncogene; 2000 Mar; 19(11):1419-27. PubMed ID: 10723133
[TBL] [Abstract][Full Text] [Related]
34. Tumor-specific bacteriophages induce tumor destruction through activation of tumor-associated macrophages.
Eriksson F; Tsagozis P; Lundberg K; Parsa R; Mangsbo SM; Persson MA; Harris RA; Pisa P
J Immunol; 2009 Mar; 182(5):3105-11. PubMed ID: 19234207
[TBL] [Abstract][Full Text] [Related]
35. [Expression of galanin in melanocytic tumors].
Gilaberte Y; Vera J; Coscojuela C; Roca MJ; Parrado C; González S
Actas Dermosifiliogr; 2007; 98(1):24-34. PubMed ID: 17374330
[TBL] [Abstract][Full Text] [Related]
36. The role of RhoC in growth and metastatic capacity of melanoma.
Boone B; Van Gele M; Lambert J; Haspeslagh M; Brochez L
J Cutan Pathol; 2009 Jun; 36(6):629-36. PubMed ID: 19222696
[TBL] [Abstract][Full Text] [Related]
37. Myeloid leukemia-1 expression in benign and malignant melanocytic lesions.
Wong RP; Khosravi S; Martinka M; Li G
Oncol Rep; 2008 Apr; 19(4):933-7. PubMed ID: 18357378
[TBL] [Abstract][Full Text] [Related]
38. Tumor-associated macrophage correlated with angiogenesis and progression of mucoepidermoid carcinoma of salivary glands.
Shieh YS; Hung YJ; Hsieh CB; Chen JS; Chou KC; Liu SY
Ann Surg Oncol; 2009 Mar; 16(3):751-60. PubMed ID: 19116756
[TBL] [Abstract][Full Text] [Related]
39. Melanoma growth stimulatory activity in primary malignant melanoma: prognostic significance.
Middleman BR; Friedman M; Lawson DH; DeRose PB; Cohen C
Mod Pathol; 2002 May; 15(5):532-7. PubMed ID: 12011258
[TBL] [Abstract][Full Text] [Related]
40. Interaction between macrophages, TGF-beta1, and the COX-2 pathway during the inflammatory phase of skeletal muscle healing after injury.
Shen W; Li Y; Zhu J; Schwendener R; Huard J
J Cell Physiol; 2008 Feb; 214(2):405-12. PubMed ID: 17657727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
